News

Mochida Pharmaceutical obtained drug marketing approval for Epadel T, indicated for triglyceride levels that are in the borderline region. The ethical drugs Epadel were converted into an OTC

The primary efficacy endpoints of both the AWARD-2 and AWARD-4 studies were non-inferiority to insulin glargine, as measured by the reduction of hemoglobin A1c (HbA1c) levels at the

As per the joint venture agreement, both the companies will equally share in decision making regarding product development and commercialization where in Agila Biotech will be a 51%

The funds will support Immunovaccine’s RSV program advancement, including formulation of RSV antigens in DepoVax vaccine adjuvanting technology. Immunovaccine chief executive officer John Trizzino said at present there

The payment technology platforms will ensure that clinical trial payments from sponsor to site and from site to subjects are compliant with relevant regulations, including the Sunshine Act.

In 2009, the American Civil Liberties Union and the Public Patent Foundation filed a suit against Myriad Genetics that has patents for BRCA1 and BRCA2 genes, mutations coupled

The 29,000ft² laboratory in Singapore offers services to clients in South Korea, Taiwan, Hong Kong, the Philippines, Australia, and India. The service offerings include chemistry, immunology, hematology, flow

The Germany-based company registered the Injex30 with the help of its exclusive distributor Hangzhou Hema Medical Equipment. The approval process, which took more than 1.5 years, has required

In addition to the CRL, the multi-specialty health care company has already received draft labeling from the FDA and expects minimal revisions to the labeling. In the CRL,